Tulane University

Scientists invent single, rapid test for both HIV and TB

Researchers at Tulane have developed a new and rapid test that can detect both HIV and tuberculosis at the same time with just a small amount of blood.

Read More →

New test uses nanotechnology, artificial intelligence to diagnose TB in children

A new blood test developed by Tulane University researchers combines nanotechnology with artificial intelligence to diagnose tuberculosis (TB) in children in instances when the deadly disease might otherwise go undetected, according to a study in Nature Biomedical Engineering.

Read More →

New blood test can help doctors diagnose TB and monitor treatment

Researchers at Tulane University School of Medicine have developed a new highly sensitive blood test for tuberculosis (TB) that screens for DNA fragments of the Mycobacterium tuberculosis bacteria that causes the deadly disease.

Read More →

Researchers develop test that detects childhood TB a year ahead of current screenings

Researchers at Tulane University School of Medicine have developed a highly sensitive blood test that can find traces of the bacteria that causes tuberculosis (TB) in infants a year before they develop the deadly disease, according to a study published in BMC Medicine

Read More →

Tulane researchers developing rapid test for tuberculosis with DOD grant

Led by Tony Hu, the Weatherhead Presidential Chair in Biotechnology Innovation at Tulane University School of Medicine, researchers at Tulane, Baylor College of Medicine and NanoPin Technologies, Inc. are now developing a rapid, reliable and highly specific test to allow rapid diagnosis of all forms of tuberculosis (TB), the leading worldwide cause of death from infectious disease.

Read More →

Tulane University awarded $6.1 million for postnatal HIV, TB study

Tuberculosis, the world’s leading infectious disease killer, is also the leading cause of death in infants with HIV. Researchers at Tulane National Primate Research Center will use a new $6.1 million grant from the National Institutes of Health to better understand how the developing immune system responds to the two diseases so that doctors can improve outcomes for infants and children across the globe.

Read More →

Researchers work to understand why HIV patients are more likely to contract TB

Researchers in the Tulane National Primate Research Center want to know more about why patients with HIV are highly susceptible to contracting tuberculosis (TB). Using two new grants, totaling $8.4 million from the National Institute of Allergy and Infectious Diseases, the Tulane team lead by Deepak Kaushal hopes to figure out how the bacterium that causes TB invades T-cells depleted by HIV. The researchers will also study if B-cells can be a source of protection against tuberculosis for patients battling HIV.

Read More →

Researchers find other layers of immunity in TB/HIV co-infections

Tulane University researchers found some monkeys whose immune systems are depleted by the simian strain of HIV have a second line of defense against tuberculosis. The discovery could have significant impacts on future vaccines for TB. The research led by study author Deepak Kaushal, Professor of Microbiology and Immunology at the Tulane National Primate Research Center has been published in the Proceedings of the National Academy of Sciences.

Read More →

Tulane researchers working on new tuberculosis vaccine

Researchers at the Tulane National Primate Research Center (TNPRC) are leading efforts to find a new vaccine for tuberculosis, one of the world’s deadliest diseases. Tuberculosis, a contagious infection of the lungs, affected more than nine million people in 2013, killing more than one million.

Read More →

Page 1 of 1 · Total posts: 9